7Baggers

Acacia Research Corporation
(NASDAQ:ACTG) 

ACTG stock logo

Acacia Research Corporation, together with its subsidiaries, intends to acquire undervalued businesses primarily in technology, life sciences, industrial, and financial services segments in the United States. The company also invests in intellectual property and related absolute return assets, as we...

Founded: 1993
Full Time Employees: 17
Sector: Industrials
Industry: Specialty Business Services
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-03-31 
                                                             
      revenues:
    		                                                         
      intellectual property operations
    		722,000 326,000 7,795,000 329,000 69,905,000 83,000 486,000 5,333,000 13,623,000 82,826,000 1,760,000 394,000 4,176,000 2,511,000 6,320,000 8,062,000 2,615,000                                         
      industrial operations
    		7,182,000 7,341,000 6,660,000 6,590,000 7,676,000 8,238,000 7,007,000 6,335,000 8,841,000 8,637,000 8,324,000 7,510,000 10,627,000 10,610,000 9,558,000 8,655,000 10,892,000                                         
      energy operations
    		18,669,000 16,019,000 14,176,000 15,317,000 18,306,000 17,340,000 15,817,000 14,170,000 1,856,000                                                 
      manufacturing operations
    		27,666,000 26,441,000 30,815,000 29,001,000 28,535,000                                                     
      total revenues
    		54,239,000 50,127,000 59,446,000 51,237,000 124,422,000 48,844,000 23,310,000 25,838,000 24,320,000 92,311,000 10,084,000 7,904,000 14,803,000 13,121,000 15,878,000 16,717,000 13,507,000                                         
      yoy
    		-56.41% 2.63% 155.02% 98.30% 411.60% -47.09% 131.16% 226.90% 64.29% 603.54% -36.49% -52.72% 9.60%                                             
      qoq
    		8.20% -15.68% 16.02% -58.82% 154.73% 109.54% -9.78% 6.24% -73.65% 815.42% 27.58% -46.61% 12.82% -17.36% -5.02% 23.77%                                          
      costs and expenses:
    		                                                         
      cost of revenues - intellectual property operations
    		4,833,000 7,242,000 8,301,000 6,558,000 27,912,000 6,078,000 5,707,000 5,765,000 7,001,000 18,946,000 5,470,000 5,010,000 4,738,000 3,549,000 5,282,000 4,634,000 4,564,000                                         
      cost of revenues - industrial operations
    		3,279,000 3,629,000 3,376,000 3,406,000 4,064,000 4,063,000 3,523,000 3,277,000 4,049,000 4,479,000 4,377,000                                               
      cost of production - energy operations
    		11,689,000 12,428,000 11,880,000 12,309,000 12,698,000 13,209,000 11,729,000 10,038,000 1,315,000                                                 
      cost of revenues - manufacturing operations
    		22,383,000 20,431,000 23,285,000 22,422,000 20,811,000                                                     
      sales and marketing expenses - industrial and manufacturing operations
    		3,119,000 3,181,000 3,080,000 3,381,000 3,312,000                                                     
      general and administrative expenses
    		17,293,000 16,301,000 15,950,000 15,546,000 17,320,000 21,935,000 11,124,000 9,951,000 12,353,000 8,356,000 13,872,000 9,426,000 12,040,000 15,867,000 15,038,000 10,722,000 11,053,000 12,652,000 10,345,000 6,503,000 6,166,000 6,387,000 7,692,000 5,519,000 4,878,000 4,201,000 4,670,000 3,810,000 3,695,000 2,284,000 6,089,000 7,098,000 3,379,000 6,734,000 6,916,000 8,334,000 7,535,000 7,994,000 7,401,000 9,442,000                  
      total costs and expenses
    		62,596,000 63,212,000 65,872,000 63,622,000 86,117,000 64,653,000 33,582,000 30,596,000 26,407,000 34,102,000 25,504,000 20,433,000 24,127,000 27,670,000 27,243,000 22,387,000 22,015,000                                         
      operating income
    		-8,357,000 -13,085,000 -6,426,000 -12,385,000 38,305,000 -15,809,000 -10,272,000 -4,758,000 -2,087,000 58,209,000 -15,420,000 -12,529,000 -9,324,000 -14,549,000 -11,365,000 -5,670,000 -8,508,000 31,299,000 -12,722,000 1,644,000 -5,676,000 -6,419,000 -2,782,000 -6,748,000 -3,569,000 -7,307,000 -5,145,000 -4,021,000 -6,945,000 11,018,000 -4,963,000 -39,836,000 8,970,000 -7,924,000 -11,576,000 16,290,000 -34,942,000 -9,702,000 -113,176,000 -26,836,000 1,000,000 -13,610,000 -15,240,000 -12,633,000 -8,231,000 -26,051,000 -31,760,000 -35,336,000 -22,930,000 7,095,000 14,659,000 -8,364,000 9,773,000 64,344,000 -4,949,000 12,410,000 20,675,000 
      yoy
    		-121.82% -17.23% -37.44% 160.30% -1935.41% -127.16% -33.39% -62.02% -77.62% -500.09% 35.68% 120.97% 9.59% -146.48% -10.67% -444.89% 49.89% -587.60% 357.30% -124.36% 59.04% -12.15% -45.93% 67.82% -48.61% -166.32% 3.67% -89.91% -177.42% -239.05% -57.13% -344.54% -125.67% -18.33% -89.77% -160.70% -3594.20% -28.71% 642.62% 112.43% -112.15% -47.76% -52.02% -64.25% -64.10% -467.17% -316.66% 322.48% -334.63% -88.97% -396.20% -167.40% -52.73%     
      qoq
    		-36.13% 103.63% -48.11% -132.33% -342.30% 53.90% 115.89% 127.98% -103.59% -477.49% 23.07% 34.37% -35.91% 28.02% 100.44% -33.36% -127.18% -346.02% -873.84% -128.96% -11.58% 130.73% -58.77% 89.07% -51.16% 42.02% 27.95% -42.10% -163.03% -322.00% -87.54% -544.10% -213.20% -31.55% -171.06% -146.62% 260.15% -91.43% 321.73% -2783.60% -107.35% -10.70% 20.64% 53.48% -68.40% -17.98% -10.12% 54.10% -423.19% -51.60% -275.26% -185.58% -84.81% -1400.14% -139.88% -39.98%  
      operating margin %
    		-15.41% -26.10% -10.81% -24.17% 30.79% -32.37% -44.07% -18.41% -8.58% 63.06% -152.92% -158.51% -62.99% -110.88% -71.58% -33.92% -62.99% Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% Infinity% -Infinity% Infinity% Infinity% -Infinity% Infinity% Infinity% 
      other income:
    		                                                         
      equity securities investments:
    		                                                         
      change in fair value of equity securities
    		-1,559,000 2,750,000 900,000 2,219,000 -4,777,000 4,107,000 -4,074,000 -4,744,000 -26,701,000 12,640,000 8,823,000 6,617,000 3,343,000 2,507,000 -36,352,000 -57,647,000 -172,203,000 -27,982,000 66,502,000 11,158,000 37,849,000                                     
      gain on sale of equity securities
    		-605,000 -3,537,000  1,907,000 1,605,000    28,861,000 -1,570,000  -7,999,000 -1,361,000 10,884,000 36,060,000 11,498,000 66,876,000 63,005,000 37,688,000 14,617,000 819,000                                     
      net realized and unrealized loss
    		-2,164,000                                                         
      loss on derivatives - energy operations
    		-10,699,000    -5,021,000                                                     
      gain on foreign currency exchange
    		-59,000 9,000 -30,000 280,000 155,000 -298,000 130,000 -70,000 -18,000 28,000 -70,000 15,000 80,000                                             
      interest expense
    		-1,886,000 -1,979,000 -2,230,000 -2,329,000 -2,451,000                                                     
      interest income
    		2,815,000 2,813,000 3,001,000 2,936,000                              580,000         304,500 293,000 369,000 556,000 545,000 554,000 397,000 442,000       20,000 
      other income
    		185,000                                 -17,000                        
      total other expense
    		-11,808,000                -79,636,000    -158,032,000     -332,250 -2,463,000                               
      income before income taxes
    		-20,165,000 5,954,000 -3,362,000 -890,000 29,609,000 -14,799,000 -6,160,000 -15,890,000 -1,298,000 73,355,000 2,565,000 -20,424,000 11,930,000 -20,391,000 29,075,000 -47,690,000 -88,144,000 228,722,000 89,615,000 20,023,000 -163,708,000 80,337,000 38,431,000 6,146,000 -12,629,000                                 
      income tax benefit
    		2,564,000 -1,181,000 968,000 -547,000 -6,081,000 776,000 -5,497,000 7,061,000 1,109,000 2,145,000 197,000 1,645,000 -2,483,000 1,812,000 -679,000 200,000 14,878,000 -23,756,000 -11,000 -510,000 -10,000 -98,000 -83,000 2,000 1,338,000                                 
      net income including noncontrolling interests in subsidiaries
    		-17,601,000 4,773,000 -2,394,000 -1,437,000 23,528,000 -14,023,000 -11,657,000  -189,000 75,500,000 2,762,000  9,447,000 -18,579,000 28,396,000 -47,490,000  204,966,000 89,604,000 19,513,000  80,239,000 38,348,000 6,148,000      -11,367,000 -32,864,000                           
      net loss attributable to noncontrolling interests in subsidiaries
    		1,860,000   -1,856,000 759,000   383,000 3,000                    14,000 -2,000 -331,000 79,000 73,000                         
      net income attributable to acacia research corporation
    		-15,741,000 3,418,000 -2,730,000 -3,293,000 24,287,000 -13,429,000 -13,996,000  -186,000 74,756,000 1,636,000  9,447,000 -18,386,000 28,090,000 -61,503,000  204,704,000 89,604,000 19,507,000  80,239,000 38,348,000 6,148,000      -11,369,000 -33,195,000     7,082,000          -24,421,000 -33,333,000 -15,711,000 -12,503,000 5,113,000 9,823,000 -6,619,000 6,321,000 49,928,000 -5,896,000 12,510,000 12,353,000 
      income per share:
    		                                                         
      net income attributable to common stockholders - basic
    		-15,741 3,418 -2,730 -3,293 24,287    -186 70,843 -1,740  5,958 -20,528 20,587 -63,443  59,172,804 72,984,000 15,108,000  65,492,000 30,529,000       -23,415,000 -33,195,000               -24,628,000 -33,487,000 -15,904,000          
      weighted-average number of shares outstanding - basic
    		96,487,121 96,293,764 96,445,160 96,244,590 96,018,047 99,213,835 99,854,723 100,079,803 99,745,905 75,296,025 94,328,452 58,408,711 47,971,931 42,460,504 38,052,426 43,988,677  48,797,290 48,949,504,000 48,729,020,000  48,840,829,000 48,467,885,000 48,457,620,000  49,764,002     49,557,748,000     50,124,302,000     49,423,472,000 49,212,207,000  48,806,334,000 48,543,334,000 48,329,375,000  48,330,149,000          
      basic net income per common share
    		-0.16 0.04 -0.03 -0.03 0.25     0.96 -0.02  0.12 -0.5 0.54 -1.44  1,212.43 1,490 310  1,340 630 90      -467.5 -670                           
      net income attributable to common stockholders - diluted
    		-15,741 3,418 -2,730 -3,293 24,287     68,911 -3,163   -20,528 1,531 -63,443  59,242,224 80,171,000 18,792,000  67,091,000 29,204,000       -23,415,000 -33,195,000               -24,628,000 -33,487,000 -15,904,000          
      weighted-average number of shares outstanding - diluted
    		96,487,121 97,158,219 96,445,160 96,244,590 96,981,413 99,213,835 99,854,723 100,079,803 99,745,905 92,411,818 99,122,973 58,408,711 89,067,821 42,460,504 71,164,236 43,988,677  98,470,870 93,081,502,000 83,086,980,000  57,435,128,000 90,624,702,000 49,033,824,000  50,896,773     49,557,748,000     50,618,757,000     49,423,472,000 49,212,207,000  48,806,334,000 48,543,334,000 48,329,375,000  48,530,105,000          
      diluted net income per common share
    		-0.16 0.03 -0.03 -0.03 0.25     0.81 -0.03   -0.5 0.02 -1.44  1,211.91 860 230  1,180 320 90      -467.5 -670                           
      other comprehensive income:
    		                                                         
      foreign currency translation
    		114 439 -114 863 662                                                     
      total other comprehensive income
    		114 439 -114 863 662                                                     
      total comprehensive income
    		-17,487 5,212 -2,508 -574 24,190                                                     
      comprehensive loss attributable to noncontrolling interests
    		1,860   -1,856 759                                                     
      comprehensive income attributable to acacia research corporation
    		-15,627 3,857 -2,844 -2,430 24,949                                                     
      net realized and unrealized gain
    		 -787,000 900,000 4,126,000 -3,172,000 4,107,000 -4,074,000 -4,744,000 2,160,000 11,862,000 12,198,000 -1,382,000 1,982,000 12,987,000 558,000 -4,064,000 -105,327,000                                         
      non-recurring legacy legal expense
    		      -2,000,000                                                   
      gain on derivatives - energy operations
    		 3,963,000 1,872,000 6,635,000  -3,530,000 8,034,000                                                   
      other expense
    		 -730,000 -449,000 -153,000                                 -1,242,000                     
      total other income
    		 19,039,000 3,064,000 11,495,000 -8,696,000 1,010,000 4,112,000 -11,132,000 789,000 15,146,000 17,985,000 -7,895,000 21,254,000 -5,842,000 40,440,000 -42,020,000  197,423,000 102,337,000 18,379,000  86,756,000 41,213,000 12,894,000 -9,060,000   -1,727,000 2,861,000 -21,988,000 -27,595,000 11,615,000 -40,890,000 -4,862,000 696,000 261,000 -52,000 -3,000     -451,000 -57,000 -196,000 109,000 161,000 280,000 400,000 1,290,000 820,000 -41,000     29,000 
      net income attributable to noncontrolling interests in subsidiaries
    		 -1,355,000 -336,000   594,000 -2,339,000   -744,000 -1,126,000   193,000 -306,000 -14,013,000  -262,000  -6,000 -900,000                                     
      comprehensive income attributable to noncontrolling interests
    		 -1,355 -336                                                       
      interest income and other
    		    1,793,000 7,170,000 2,022,000 295,000 4,890,000 3,256,000 4,462,000 4,307,000 3,441,000 2,351,000 1,221,000 863,000 1,007,000 366,000 76,000 85,000 -26,000 27,000 10,000 266,000 535,000 2,082,000 718,000 1,130,000 1,543,000 173,000 321,000 268,000 207,000                         
      engineering and development expenses - industrial operations
    		     105,000 108,000 178,000 134,000 142,000 172,000 205,000 216,000 135,000 156,000 145,000 190,000                                         
      sales and marketing expenses - industrial operations
    		     1,083,250 1,391,000 1,387,000 1,555,000 1,523,000 1,613,000 1,859,000 1,913,000 2,192,000 2,119,000 2,294,000 2,016,000                                         
      earnings on equity investment in joint venture
    		         792,000 3,375,000   -404,000 850,000 42,085,000  793,000  7,000 2,730,000                                     
      change in fair value of the series b warrants and embedded derivatives
    		                                                         
      interest expense on senior secured notes
    		          -130,000 -900,000 -900,000 -900,000 -1,072,000 -1,859,000 -2,601,000 -2,321,000 -2,531,000 -1,760,000 -1,310,000 -2,745,000 -2,410,000 -768,000                                  
      loss per share:
    		                                                         
      net loss attributable to common stockholders - basic
    		     -5,657 -13,996 -8,446    -21,155                             -3,896,000 -13,345,000 -12,589,000 -12,575,000 -13,154,000             
      basic net loss per common share
    		     -0.058 -0.14 -0.08    -0.36                                              
      net loss attributable to common stockholders - diluted
    		     -5,657 -13,996 -8,446 -186   -21,155 -6,496                            -3,896,000 -13,345,000 -12,589,000 -12,575,000 -13,154,000             
      diluted net loss per common share
    		     -0.058 -0.14 -0.08    -0.36 -0.07                                             
      legal liability fee
    		       -6,613,000 -6,243,000                                                 
      net loss including noncontrolling interests in subsidiaries
    		       -8,829,000    -18,779,000     -73,266,000    -163,718,000    -11,291,000 634,000 -7,608,000 -5,757,000 -4,398,000   -28,506,000 -32,111,000                         
      net loss attributable to acacia research corporation
    		       -8,446,000    -18,779,000     -73,266,000    -164,618,000    -11,291,000 634,000 -7,608,000 -5,757,000 -4,384,000   -28,427,000 -32,038,000    -40,573,000 -9,965,000 -115,910,000 -27,310,000 -3,686,000 -13,130,000 -12,446,250 -12,415,000 -12,949,000             
      change in fair value of the series a and b warrants and embedded derivatives
    		          1,525,000 -9,935,000 16,651,000 -21,488,000 41,638,000 -35,146,000 28,098,000 163,458,000 619,000 -5,576,000 -198,909,000 -11,626,000 20,672,000 -62,902,000 -4,382,000                                 
      cost of sales - industrial operations
    		           3,933,000 5,220,000 5,927,000 4,648,000 4,592,000 4,192,000                                         
      change in fair value of investment
    		                     1,770,000 -3,081,000 2,677,000 4,108,000 277,000 -4,266,000 6,980,000 6,908,000 -6,976,000 -22,377,000 11,347,000 -41,097,000 -12,698,000                        
      gain on sale of investment
    		                    839,000   554,000                                  
      loss on foreign currency exchange
    		             1,208,000 -1,905,000 -1,814,000 -813,000 104,000 -17,000 -152,000 -24,000 33,000 -48,000 -4,890,000                                  
      net loss attributable to common stockholders - basic and diluted
    		                -75,117    -136,665,000    -12,185,000 -4,437,250 -7,608,000 -5,757,000 -4,384,000   -28,427,000 -32,038,000    -40,573,000 -9,965,000 -116,039,000 -27,450,000                  
      weighted-average number of shares outstanding - basic and diluted
    		                46,544,313    48,596,040,000    49,875,396,000  49,828,361,000 49,696,016,000 49,655,881,000   50,061,812,000 50,632,958,000 50,499,248,000 50,333,056,000  50,015,869,000 49,925,550,000  49,630,369,000                  
      basic and diluted net loss per common share
    		                -1.61    -2,810    -240 -90 -150 -120 -90   -570 -630                         
      revenues
    		                 6,196,250 1,582,000 17,400,000 5,803,000 4,383,000 19,466,000 2,118,000 3,815,000 688,000 1,711,000 5,460,000 3,387,000 49,203,000 13,725,000 6,485,000 62,093,000 16,457,000 8,854,000 64,658,000 41,351,000 24,721,000 37,497,000 12,994,000 40,336,000 34,210,000 31,030,000 37,192,000 50,076,000 12,578,000 15,065,000 15,520,000 23,110,000 76,861,000 66,264,000 34,939,000 50,484,000 99,040,000 20,795,000 50,585,000 61,130,000 
      patent portfolio operations:
    		                                                         
      inventor royalties
    		                 205,750 280,000 448,000 95,000 506,000 5,772,000 645,000 426,000 192,000 776,000 2,623,000 1,353,000 11,002,000 1,181,000 1,241,000 21,744,000 4,273,000 666,000 17,844,000  1,573,000 7,756,000 116,000 1,265,000 9,325,000 4,358,000 4,667,000 10,694,000 951,000 3,280,000 2,353,000 5,610,000 18,481,000 3,829,000 5,032,000 9,573,000 7,594,000 6,458,000 15,592,000 13,089,000 
      contingent legal fees
    		                 1,433,750 285,000 4,356,000 1,094,000 564,000 6,609,000 12,000 234,000 4,000 35,000 375,000 177,000 11,756,000 2,949,000 1,037,000 15,759,000 3,236,000 627,000 7,709,000 10,418,000 4,109,000 3,901,000 1,972,000 5,512,000 4,784,000 7,296,000 7,663,000 7,077,000 1,527,000 3,181,000 2,547,000 4,024,000 15,032,000 5,463,000 8,833,000 6,607,000 3,748,000 5,547,000 12,328,000 9,367,000 
      litigation and licensing expenses - patents
    		                 1,220,250 782,000 1,837,000 2,262,000 2,186,000 1,001,000 1,459,000 1,037,000 1,160,000 987,000 1,855,000 3,801,000 2,760,000 1,231,000 2,130,000 2,745,000 4,134,000 6,386,000 7,348,000 7,324,000 7,723,000 11,341,000 10,345,000 9,012,000 8,675,000 8,208,000 9,592,000 10,820,000 8,994,000 8,899,000 10,870,000 9,918,000 9,648,000 6,969,000 5,973,000 5,268,000 3,381,000 2,205,000 3,501,000 3,534,000 
      amortization of patents
    		                 1,771,500 2,612,000 2,612,000 1,862,000 1,159,000 1,174,000 1,305,000 1,043,000 857,000 863,000 818,000 656,000 11,560,000 4,952,000 5,278,000 5,330,000 5,571,000 5,515,000 6,467,000 10,759,000 10,760,000 13,113,000 13,688,000 13,228,000 13,038,000 13,727,000 13,511,000 15,532,000 14,472,000 16,735,000 12,615,000 12,578,000 11,730,000 18,088,000 10,412,000 5,393,000 5,126,000 1,427,000 1,946,000 3,772,000 
      other patent portfolio income
    		                                                         
      patent portfolio expenses
    		                 4,631,250 3,959,000 9,253,000 5,313,000                                     
      net patent portfolio income
    		                 1,565,000 -2,377,000 8,147,000 490,000                                     
      gain on sale of prepaid investment and derivative
    		                      2,845,000                                   
      other patent portfolio expenses
    		                                                         
      portfolio operations:
    		                                                         
      other portfolio expenses
    		                       -74,000 -234,000 1,581,000 -475,000  650,000                             
      total portfolio operations
    		                     4,415,000 14,556,000 3,347,000 2,506,000 3,794,000 2,186,000 5,671,000 6,637,000                             
      net portfolio income
    		                     -32,000 4,910,000 -1,229,000 1,309,000 -3,106,000 -475,000 -211,000 -3,250,000                             
      loss on sale of investment
    		                     -690,500   -3,316,000 -1,083,000 -915,000 -1,642,000 -5,590,000 -13,556,000 -5,539,000                           
      impairment of other investment
    		                           -8,195,000                              
      gain on disposal of other investment
    		                          2,000,000                               
      change in fair value of equity securities derivative and forward contract
    		                     4,385,500 -64,011,000 81,553,000                                  
      change in fair value of trading securities and equity securities - private
    		                     20,476,750 84,499,000                                   
      gain on sale of trading securities
    		                     11,624,000 2,737,000 -7,121,000 112,000                                 
      change in fair value of trading securities
    		                       3,525,000 -6,117,000                                 
      net income attributable to common stockholders - basic and diluted
    		                       4,201,000            7,043,000                      
      less: dividend on series a redeemable convertible preferred stock
    		                        -263,000                                 
      less: accretion of series a redeemable convertible preferred stock
    		                        -631,000                                 
      patent acquisition expenses
    		                                                         
      impairment of patent-related intangible assets
    		                                                         
      income before provision for income taxes
    		                         -4,360,000 -7,608,000 -5,748,000 -4,084,000 -23,174,750 -32,558,000 -28,221,000 -31,920,000 -12,786,000 -10,880,000 16,551,000 -34,994,000 -9,705,000 -9,875,500 -27,016,000 896,000         8,385,000        
      provision for income taxes
    		                         -80,750  -9,000 -314,000 -397,000 -306,000 -285,000 -191,000 -1,478,000 -1,241,000 -9,655,000 -5,927,000 -192,000 -156,500 -337,000 -119,000         -3,272,000   -3,494,000 -14,747,000 -1,072,000 -182,000 -7,148,000 
      operating costs and expenses:
    		                                                         
      cost of revenues:
    		                                                         
      other patent acquisition costs
    		                             1,000,000                            
      other - business development
    		                             144,250 84,000                           
      impairment of patent-related intangible and other assets
    		                             7,302,500  29,210,000                          
      other expenses
    		                             550,500 2,202,000                           
      total operating costs and expenses
    		                             29,533,000 18,688,000 46,321,000 53,123,000 24,381,000 20,430,000 48,368,000 76,293,000 34,423,000 150,673,000 39,830,000 39,336,000 47,820,000 46,270,000 49,825,000 58,307,000 38,629,000 46,825,000 50,856,000 46,040,000 69,766,000 51,605,000 43,303,000 40,711,000 34,696,000 25,744,000 38,175,000 40,455,000 
      gain on conversion of loans and accrued interest
    		                                 2,671,000                        
      gain on exercise of primary warrant
    		                                 4,616,000                        
      equity in losses of investee
    		                                                         
      other
    		                                4,000,000     1,742,000 250,000 3,465,000  426,000  1,548,000    3,506,000          
      other expenses - business development
    		                               327,000 166,000                         
      research, consulting and other expenses - business development
    		                                 433,000 320,000 666,000 1,334,000 522,000 860,000 802,000 732,000 997,000 637,000 1,208,000 1,003,000 992,000 771,000 730,000 726,000 1,024,000 721,000 1,139,000 1,967,000 1,116,000 1,445,000 850,000 708,000 
      equity in earnings of investee
    		                                 -14,000                        
      loss including noncontrolling interests in operating subsidiaries
    		                                 -14,264,000 -12,121,000   -9,897,000 -10,032,000 -27,353,000                  
      net loss attributable to noncontrolling interests in operating subsidiaries
    		                                 12,000 291,000 186,000 348,000 -68,000 1,440,000 43,000 -4,463,000 422,000 -103,000 420,000 167,000 149,000 1,656,000 -225,000 977,000  101,000 -152,000 -60,000 275,000 -161,500 257,000  
      loss attributable to acacia research corporation
    		                                 -14,252,000 -11,830,000                       
      basic and diluted loss per common share
    		                                 -280 -240  -810 -200 -2,350 -550                  
      income including noncontrolling interests in operating subsidiaries
    		                                   6,896,000 -40,921,000                     
      basic and diluted income per common share
    		                                   140                      
      cash dividends declared per common share
    		                                      125 125 125 125 125 125 125 125            
      write-off of patent-related intangible assets
    		                                    40,165,000                     
      total interest and other investment loss
    		                                      -14,000 -180,000                  
      marketing, general and administrative expenses
    		                                        9,587,000 10,575,000 12,044,000 11,636,000 13,181,000 11,693,000 13,959,000 18,235,000 13,184,000 13,851,000 16,535,000 11,914,000 11,903,000 13,731,000 8,662,000 8,748,000 9,985,000 
      total interest and other investment income
    		                                        -104,000 228,000                
      net income including noncontrolling interests in operating subsidiaries
    		                                        777,000     -24,570,000 -34,989,000 -15,486,000 -13,480,000 5,113,000 9,722,000 -6,467,000 6,381,000 49,653,000 -6,003,000 12,253,000 13,556,000 
      basic loss per common share
    		                                        -80 -270 -260 -260 -270             
      diluted loss per common share
    		                                        -80 -270 -260 -260 -270             
      loss before benefit from income taxes
    		                                         -13,382,000 -11,764,750 -12,690,000 -8,427,000             
      benefit from income taxes
    		                                         -170,000 -450,000 -145,000 -4,689,000 1,372,000 -3,390,000 19,570,000 9,050,000  -4,075,750 1,938,000      
      net loss including noncontrolling interests in operating subsidiaries
    		                                         -13,552,000 -12,630,250 -12,835,000 -13,116,000             
      net realized gain on investments
    		                                          -340,500 -350,000 -565,000             
      net gain on investments
    		                                             -447,000 144,250 -274,000 3,000 848,000        
      income before benefit from income taxes
    		                                             -25,942,000 -12,300,250 -35,056,000 -22,530,000         
      basic income per common share
    		                                             -510 -690 -330          
      diluted income per common share
    		                                             -510 -690 -330          
      write off of investment
    		                                                         
      net income per common share attributable to acacia research corporation:
    		                                                         
      basic earnings per share
    		                                                -0.26 0.11 0.265 -0.14 0.13 1.13 0.173 0.3  
      diluted earnings per share
    		                                                -0.26 0.11 0.26 -0.14 0.13 1.09 0.165 0.29  
      weighted-average number of shares outstanding, basic
    		                             49,969,062,000             48,658,088,000    48,155,832,000  48,008,998 47,859,774 47,251,061 48,332,878 47,944,193 44,367,499 39,743,433 41,292,819 35,182,811 
      weighted-average number of shares outstanding, diluted
    		                             49,969,062,000             48,658,088,000    48,155,832,000  48,008,998 48,354,444 48,060,647 48,332,878 48,938,766 45,771,228 41,258,297 42,857,880 36,448,005 
      verdict insurance proceeds
    		                                                       -12,451,000  
      verdict insurance proceeds related costs
    		                                                       7,661,000  
      income from operations before benefit from income taxes
    		                                                  16,467,500 -8,405,000      
      interest and investment income
    		                                                    102,000 56,000 18,000 25,000  
      income from operations before provision for income taxes
    		                                                    9,875,000 64,400,000 -4,931,000 12,435,000 20,704,000 
      net income per common share attributable toacacia research corporation:
    		                                                         
      gain on investments
    		                                                        9,000 
      net income attributable to noncontrolling interests in operating subsidiaries
    		                                                        -1,203,000 
      basic income per share
    		                                                        0.35 
      diluted income per share
    		                                                        0.34 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-03-31 
                                                               
        assets
      		                                                         
        current assets:
      		                                                         
        cash and cash equivalents
      		307,507,000 306,719,000 301,780,000 316,721,000 271,964,000 273,880,000 360,050,000 386,988,000 438,762,000 340,091,000 344,733,000 355,188,000 364,227,000 287,786,000 241,874,000 263,945,000 289,369,000 308,943,000 217,957,000 185,710,000 144,807,000 165,546,000 162,564,000 164,280,000 58,678,000 57,359,000 66,861,000 63,487,000 73,285,000 128,809,000 109,562,000 100,150,000 150,289,000 63,220,000 54,321,000 116,016,000 139,772,000 145,329,000 135,223,000 157,775,000 119,084,000 101,548,000 134,466,000 154,257,000 146,040,000 133,403,000 126,685,000 118,303,000 148,909,000 193,161,000 221,804,000 264,151,000 296,866,000 315,498,000 314,733,000 310,663,000 313,611,000 
        equity securities
      		14,206,000 17,551,000 27,193,000 21,467,000 18,064,000 23,135,000 14,100,000 18,174,000 22,918,000 63,068,000 64,511,000 52,853,000 60,724,000 61,608,000                                            
        equity securities without readily determinable fair value
      		5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 5,816,000 176,010,000 116,946,000                                     
        equity method investments
      		30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000 30,934,000                                            
        loans receivable
      		8,137,000 15,299,000 3,392,000                                                       
        accounts receivable
      		28,694,000 26,165,000 27,141,000 23,370,000 95,725,000 26,909,000 10,733,000 18,772,000 15,372,000 80,555,000 5,896,000 6,267,000 8,666,000 8,231,000 7,040,000 13,692,000 9,141,000 9,517,000 412,000 12,750,000 4,425,000 506,000 263,000 1,393,000 621,000 511,000 1,799,000 15,308,000 23,964,000 32,884,000 10,572,000 5,629,000 4,754,000 14,245,000 7,781,000 53,700,000 4,325,000 25,175,000 33,500,000 12,757,000 37,550,000 30,007,000 20,168,000 12,702,000 25,185,000 13,540,000 6,341,000 16,812,000 16,781,000 45,351,000 9,843,000 16,635,000 10,822,000 1,280,000 2,915,000 32,560,000 1,198,000 
        inventories
      		23,417,000 26,559,000 26,490,000 25,724,000 26,264,000 27,485,000 12,218,000 12,289,000 9,880,000 10,921,000 12,375,000 14,006,000 14,725,000 14,222,000 13,802,000 12,056,000 10,014,000 8,930,000                                        
        prepaid expenses and other current assets
      		12,394,000 21,050,000 17,891,000 19,958,000 15,866,000 31,987,000 23,795,000 20,961,000 29,465,000 23,127,000 20,182,000 20,728,000 20,099,000 19,388,000 5,173,000 5,291,000 4,961,000 4,764,000 3,986,000 2,283,000 2,647,000 5,832,000 1,685,000 1,894,000 3,653,000 2,912,000 2,329,000 3,289,000 3,686,000 3,125,000 3,121,000 3,509,000 3,801,000 4,116,000 5,138,000 3,773,000 4,310,000 4,352,000 4,219,000 4,926,000 5,146,000 5,057,000 4,355,000 5,794,000 5,790,000 7,617,000 7,546,000 7,414,000 8,455,000 5,101,000 3,441,000 3,045,000 1,786,000 2,431,000 803,000 927,000 2,167,000 
        total current assets
      		431,105,000 450,093,000 440,637,000 443,990,000 464,633,000 420,146,000 457,646,000 493,934,000 553,147,000 554,512,000 484,447,000 485,792,000 505,191,000 427,985,000 427,195,000 500,165,000 596,719,000 730,682,000 669,431,000 544,460,000 482,810,000 457,669,000 366,050,000 364,123,000 162,385,000 171,765,000 173,459,000 183,500,000 195,522,000 201,472,000 157,103,000 143,982,000 188,203,000 136,633,000 169,682,000 218,066,000 194,896,000 186,589,000 183,877,000 187,340,000 210,749,000 201,780,000 218,708,000 248,351,000 254,952,000 253,289,000 273,728,000 329,501,000 345,361,000 377,900,000 324,563,000 430,478,000 441,970,000 453,394,000 325,048,000 350,664,000 316,976,000 
        property, plant and equipment
      		20,231,000 21,291,000 22,188,000 22,751,000 23,354,000 23,865,000 2,366,000 2,315,000 2,090,000 2,356,000 2,647,000 2,950,000 3,275,000 3,537,000 3,700,000 3,883,000 3,885,000 4,183,000                                        
        oil and natural gas properties
      		195,879,000 190,705,000 188,877,000 187,095,000 189,104,000 191,680,000 190,149,000 192,587,000 24,952,000 25,117,000                                                
        goodwill
      		25,735,000 25,790,000 25,695,000 25,782,000 25,566,000 29,339,000 8,990,000 8,990,000 8,990,000 8,990,000 7,541,000 7,541,000 7,541,000 7,541,000 7,470,000 7,470,000 7,470,000 7,470,000                      30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 30,149,000 36,217,000 36,217,000 36,202,000    
        other intangible assets
      		45,294,000 48,148,000 55,458,000 61,643,000 67,739,000 55,429,000 30,872,000 36,017,000 29,690,000 33,556,000 27,557,000 30,590,000 33,624,000 36,658,000 39,692,000 42,725,000 45,759,000 48,793,000                                        
        operating lease, right-of-use assets
      		11,657,000 11,500,000 11,643,000 10,397,000 8,001,000 9,287,000 1,366,000 1,639,000 1,717,000 1,872,000                                                
        deferred income tax assets
      		18,290,000 14,836,000 16,939,000 16,998,000 17,231,000 20,233,000 8,424,000 13,854,000 6,567,000 2,915,000 321,000                                               
        other non-current assets
      		7,680,000 8,593,000 7,434,000 6,890,000 5,978,000 6,415,000 7,759,000 4,257,000 4,572,000 4,227,000 5,146,000 6,925,000 5,359,000 5,202,000 4,819,000 5,041,000 5,273,000 5,283,000 4,482,000 4,653,000 4,834,000 4,988,000 5,311,000 5,466,000 1,004,000 818,000 2,126,000 1,658,000 216,000 236,000                            
        total assets
      		755,871,000 770,956,000 768,871,000 775,546,000 801,606,000 756,394,000 707,572,000 753,593,000 631,725,000 633,545,000 529,147,000 534,708,000 556,604,000 482,928,000 485,269,000 561,699,000 661,440,000 798,856,000 749,834,000 627,732,000 568,958,000 515,520,000 426,515,000 394,146,000 213,721,000 218,161,000 186,930,000 203,762,000                              
        liabilities and stockholders' equity
      		                                                         
        current liabilities:
      		                                                         
        accounts payable
      		11,431,000 13,358,000 13,331,000 10,972,000 12,457,000 12,074,000 5,258,000 3,191,000 4,702,000 3,261,000 8,530,000 5,789,000 8,413,000 6,036,000 5,097,000 5,484,000 5,298,000 5,440,000 2,196,000 2,625,000 3,633,000 1,019,000 2,707,000 3,235,000 3,136,000 1,765,000                                
        accrued expenses and other current liabilities
      		23,480,000 19,661,000 20,326,000 22,677,000 24,084,000 20,575,000 8,668,000 15,207,000 3,990,000 8,405,000 5,256,000 4,461,000 12,694,000 14,058,000 9,258,000 6,841,000 7,349,000 5,789,000 5,586,000 4,817,000 3,673,000 3,707,000 4,849,000 2,716,000 4,376,000 7,265,000                                
        accrued compensation
      		5,955,000 6,727,000 7,990,000 6,394,000 6,879,000 6,277,000 4,969,000 3,983,000 4,624,000 4,207,000 5,202,000 5,505,000 5,490,000 4,737,000 5,070,000 4,108,000 4,345,000 4,136,000 4,019,000 2,382,000 2,017,000 2,265,000 2,595,000 1,998,000 1,127,000 507,000                                
        current asset retirement obligation
      		1,608,000 1,589,000 1,569,000 1,585,000 1,565,000 1,546,000 1,562,000                                                   
        royalties and contingent legal fees payable
      		6,630,000 6,761,000 6,978,000 5,681,000 26,699,000 5,448,000 6,194,000 4,869,000 3,011,000 10,786,000 1,296,000 579,000 1,060,000 699,000 3,259,000 2,581,000 2,303,000 2,463,000 1,793,000 6,089,000 2,445,000 2,162,000 14,230,000 2,143,000 2,070,000 2,178,000 2,274,000 10,518,000 16,149,000 22,688,000 7,193,000 4,765,000 39,937,000 9,427,000 3,078,000 25,009,000 17,854,000 18,618,000 14,878,000 9,243,000 20,181,000 19,129,000 14,351,000 17,777,000 20,312,000 3,895,000 10,447,000 8,313,000 19,986,000 36,736,000 12,508,000 21,478,000 19,103,000 14,095,000 23,508,000 37,050,000 21,736,000 
        deferred revenue
      		1,260,000 945,000 853,000 731,000 1,403,000 1,319,000 1,268,000 911,000 1,069,000 977,000 1,149,000 1,022,000 1,206,000 1,229,000 1,403,000 1,378,000 1,453,000 1,114,000                                        
        total current liabilities
      		50,364,000 49,041,000 51,047,000 50,440,000 75,487,000 47,239,000 27,919,000 44,204,000 25,846,000 27,636,000 21,433,000 77,806,000 90,213,000 87,209,000 85,437,000 136,220,000 194,409,000 200,190,000 204,449,000 171,390,000 137,979,000 124,816,000 138,314,000 123,493,000 10,709,000 11,715,000 10,571,000 20,014,000 31,347,000 31,035,000 16,260,000 13,620,000 48,977,000 18,666,000 14,790,000 47,922,000 29,278,000 33,198,000 33,225,000 26,720,000 31,706,000 32,734,000 45,911,000 38,341,000 43,100,000 35,440,000 26,002,000 33,373,000 42,086,000 53,863,000 21,993,000 37,866,000 37,751,000 22,502,000 30,133,000 44,251,000 30,915,000 
        asset retirement obligation
      		33,027,000 32,586,000 32,232,000 31,814,000 31,401,000 31,070,000 28,065,000 1,543,000                                                  
        long-term lease liabilities
      		8,867,000 8,424,000 8,713,000 7,551,000 5,872,000 6,778,000 1,251,000 1,447,000 1,477,000 1,736,000 1,535,000 898,000 1,566,000 1,873,000 2,186,000 2,254,000 2,298,000 2,027,000 671,000 759,000 845,000 951,000 1,101,000 1,249,000 1,395,000 1,264,000                                
        deferred income tax liabilities
      		2,182,000 2,152,000 2,609,000 2,697,000 2,697,000 2,609,000      125,000 502,000 742,000 2,710,000 3,052,000 3,513,000 18,552,000                                        
        benchmark revolving credit facility
      		59,500,000 59,500,000 58,500,000 58,000,000                                                      
        deflecto facility
      		31,021,000 32,566,000 35,519,000 43,983,000                                                      
        other long-term liabilities
      		3,685,000 2,655,000 3,413,000 3,590,000 2,901,000 2,091,000 1,771,000 1,479,000 1,417,000 3,581,000 2,084,000 1,858,000 1,674,000 1,675,000 1,781,000 1,066,000 1,165,000 6,161,000 5,591,000 5,591,000 5,591,000 591,000 593,000 593,000 583,000 593,000                                
        total liabilities
      		188,646,000 186,924,000 192,033,000 198,075,000 224,346,000 203,775,000 129,006,000 156,848,000 42,121,000 43,936,000 25,549,000 176,121,000 179,439,000 193,682,000 184,306,000 276,380,000 300,064,000 353,628,000 500,286,000 467,934,000 429,033,000 212,067,000 214,090,000 220,090,000 43,210,000 35,114,000 12,621,000 22,145,000 32,263,000 32,709,000 18,134,000 16,091,000 50,782,000 19,243,000 15,170,000 48,494,000 29,842,000 33,753,000 33,746,000 28,172,000 33,138,000 34,145,000 47,300,000 41,994,000 46,625,000 39,506,000 31,195,000 52,443,000 61,688,000 82,188,000 50,239,000 72,141,000 70,997,000 55,507,000 30,765,000 44,859,000 31,564,000 
        commitments and contingencies
      		                                                         
        stockholders' equity:
      		                                                         
        preferred stock, par value 0.001 per share...
      		                                                         
        common stock, par value 0.001 per share...
      		96,000 96,000 96,000 96,000 96,000 96,000 99,000 100,000 100,000 100,000 99,000 58,000 58,000 43,000 38,000 41,000 47,000 49,000 50,000 50,000 49,000 49,000 49,000 49,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 49,000 51,000 51,000 51,000 50,000 50,000 50,000 51,000 51,000 51,000 51,000 50,000 50,000 50,000 50,000 49,000 50,000 50,000 49,000 49,000 50,000 50,000 50,000 43,000 43,000 43,000 
        treasury stock
      		-118,542,000 -118,542,000 -118,542,000 -118,542,000 -118,542,000 -118,542,000 -105,560,000 -98,258,000 -98,258,000 -98,258,000 -98,258,000 -98,258,000 -98,258,000 -98,258,000 -98,258,000 -86,781,000 -58,267,000 -47,281,000 -43,270,000 -43,270,000 -43,270,000 -43,270,000 -43,270,000 -43,270,000 -40,586,000 -39,272,000 -39,272,000 -39,272,000 -39,272,000 -39,272,000 -39,272,000 -39,272,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -34,640,000 -26,731,000 -26,731,000 -26,731,000 -26,731,000       
        accumulated other comprehensive income
      		784,000 670,000 231,000 345,000 -518,000 -1,180,000                                                    
        additional paid-in capital
      		916,010,000 915,330,000 913,348,000 911,473,000 910,688,000 910,237,000 907,996,000 907,215,000 906,337,000 906,153,000 905,200,000 738,712,000 740,187,000 663,284,000 644,329,000 646,352,000 647,640,000 648,389,000 649,349,000 650,194,000 650,753,000 651,416,000 650,130,000 650,843,000 651,441,000 652,003,000 651,988,000 651,688,000 651,148,000 651,156,000 650,814,000 650,265,000 649,724,000 646,627,000 644,794,000 639,118,000 636,332,000 634,882,000 633,146,000 637,029,000 641,207,000 644,404,000 646,595,000 648,760,000 651,053,000 650,934,000 653,314,000 653,326,000 651,346,000 650,966,000 644,982,000 631,000,000 627,825,000 618,683,000 386,821,000 382,576,000 375,271,000 
        accumulated deficit
      		-269,845,000 -254,104,000 -257,522,000 -254,792,000 -251,499,000 -275,786,000 -262,357,000 -248,361,000 -239,915,000 -239,729,000 -314,485,000 -316,121,000 -297,342,000 -306,789,000 -288,403,000 -316,493,000 -254,990,000 -181,724,000 -382,215,000 -471,819,000 -491,326,000 -326,708,000 -406,451,000 -444,799,000 -450,947,000 -439,656,000 -440,290,000 -432,682,000 -426,925,000 -422,541,000 -411,172,000 -377,977,000 -349,550,000 -368,280,000 -354,028,000 -331,587,000 -338,669,000 -298,096,000 -288,131,000 -172,221,000 -144,911,000 -141,225,000 -128,095,000 -111,851,000 -99,436,000 -86,487,000 -62,066,000 -28,733,000 -13,022,000 -519,000 -5,632,000 -15,455,000 -8,836,000 -15,157,000 -65,085,000 -59,189,000 -73,838,000 
        total acacia research corporation stockholders' equity
      		528,503,000 543,450,000 537,611,000 538,580,000 540,225,000 514,825,000 540,178,000 560,696,000 568,264,000 568,266,000 492,556,000 324,391,000 344,645,000 258,280,000 257,706,000 243,119,000 334,430,000 419,433,000 223,914,000 135,155,000 116,206,000 281,487,000 200,458,000 162,823,000 159,958,000 173,125,000 172,476,000 179,784,000                          604,176,000 319,949,000 321,517,000 301,476,000 
        noncontrolling interests
      		38,722,000 40,582,000 39,227,000 38,891,000 37,035,000 37,794,000 38,388,000 36,049,000 21,340,000 21,343,000 11,042,000 11,042,000 11,042,000 11,042,000 24,775,000 25,055,000 11,042,000 11,042,000 11,948,000 11,948,000 11,942,000 11,042,000 1,833,000 1,833,000 1,833,000 1,833,000 1,833,000 1,833,000 1,833,000  1,844,000 1,513,000 1,593,000                         
        total stockholders' equity
      		567,225,000 584,032,000 576,838,000 577,471,000 577,260,000 552,619,000 578,566,000 596,745,000 589,604,000 589,609,000 503,598,000 335,433,000 355,687,000 269,322,000 282,481,000 268,174,000 345,472,000 430,475,000 235,862,000 147,103,000 128,148,000 292,529,000 202,291,000 164,656,000 161,791,000 174,958,000 174,309,000 181,617,000                          607,984,000 322,112,000 323,125,000 305,658,000 
        total liabilities and stockholders' equity
      		755,871,000 770,956,000 768,871,000 775,546,000 801,606,000 756,394,000 707,572,000 753,593,000 631,725,000                  186,930,000 203,762,000                              
        current portion of long-term debt
      		   2,400,000 2,400,000                                                     
        revolving credit facility
      		    61,500,000 66,500,000 70,000,000 82,000,000 13,025,000 10,525,000                                                
        term loan and revolving credit facility
      		    44,488,000                                                     
        term loan
      		     47,488,000                                                    
        accrued loss contingency
      		       14,500,000 8,450,000                                                 
        deferred revenue, net of current portion
      		        356,000 458,000 497,000 535,000 520,000 568,000 665,000 623,000 660,000 581,000                                        
        liabilities, redeemable convertible preferred stock, and stockholders' equity
      		                                                         
        senior secured notes payable
      		           60,450,000 61,350,000 60,450,000 61,350,000 115,828,000 168,661,000 181,248,000 182,855,000                                       
        series a embedded derivative liabilities
      		           12,881,000 11,812,000 16,835,000 22,389,000 23,599,000 14,506,000 18,448,000 41,411,000 41,191,000 40,419,000 26,728,000 25,682,000 29,513,000 21,682,000 17,974,000                                
        series b warrant liabilities
      		           82,018,000 73,152,000 84,780,000 59,742,000 96,781,000 73,118,000 96,378,000 229,637,000 230,539,000 225,956,000 52,341,000 42,796,000 58,290,000 6,231,000                                 
        series a redeemable convertible preferred stock, par value 0.001 per share...
      		           23,154,000 21,478,000 19,924,000 18,482,000 17,145,000 15,904,000 14,753,000 13,686,000 12,695,000 11,777,000 10,924,000 10,134,000 9,400,000 8,720,000 8,089,000                                
        total liabilities, redeemable convertible preferred stock, and stockholders' equity
      		         633,545,000 529,147,000 534,708,000 556,604,000 482,928,000 485,269,000 561,699,000 661,440,000 798,856,000 749,834,000 627,732,000 568,958,000 515,520,000 426,515,000 394,146,000 213,721,000 218,161,000                                
        leased right-of-use assets
      		          1,488,000 910,000 1,614,000 2,005,000 2,393,000 2,415,000 2,334,000 2,027,000 671,000 759,000 845,000 951,000 1,101,000 1,249,000 1,395,000 1,264,000                                
        long-term restricted cash
      		                 418,000 35,424,000 35,422,000 35,419,000 35,000,000 35,000,000  35,000,000 35,000,000                                
        series a warrant liabilities
      		              9,396,000 12,785,000 10,395,000 11,291,000 18,527,000 18,464,000 18,243,000 6,640,000 5,604,000 6,952,000 2,610,000 3,568,000                                
        equity securities at fair value
      		              81,384,000 126,345,000 246,484,000 361,778,000 387,120,000 134,938,000 180,320,000                                     
        investment securities - equity method investments
      		              72,106,000 73,020,000 30,934,000 30,934,000 31,840,000 31,839,000 33,665,000 30,673,000                                    
        accrued patent investment costs
      		                5,000,000  8,000,000 10,000,000 10,000,000        3,750,000       225,000   1,000,000   900,000 16,700,000 4,000,000 6,000,000 19,250,000            
        investment at fair value
      		                     2,752,000 982,000 4,063,000 1,387,000 1,500,000 2,674,000 9,070,000 5,483,000 7,459,000 36,648,000 75,004,000 63,657,000 49,817,000                        
        restricted cash
      		                  761,000 930,000               11,515,000 14,041,000 14,036,000 11,523,000 10,725,000 10,721,000 10,718,000 10,718,000                
        other receivable
      		                  21,539,000                                       
        patents, net of accumulated amortization
      		                  39,826,000 42,438,000 45,050,000 16,912,000 18,071,000 19,245,000 12,550,000 7,814,000 8,671,000 9,534,000 9,681,000 6,587,000 18,147,000 23,099,000 56,587,000 75,233,000 80,804,000    162,642,000 249,486,000 262,337,000 274,659,000 286,636,000 269,435,000 282,524,000 290,197,000 288,432,000 296,272,000 303,489,000 305,809,000 313,529,000 226,317,000 214,204,000 171,262,000 25,188,000 14,665,000 17,586,000 
        senior secured notes payable - short-term
      		                   145,477,000 116,211,000 115,663,000 113,933,000                                   
        trading securities - debt
      		                        88,963,000 93,843,000 86,390,000 90,482,000 93,756,000 33,642,000                            
        trading securities - equity
      		                     109,103,000 24,471,000 19,697,000 10,470,000 17,140,000 16,080,000 10,934,000 831,000 3,012,000                            
        investment securities - private equity
      		                     143,257,000                                    
        equity securities - private
      		                      116,009,000                                   
        equity securities derivative
      		                      17,818,000 7,369,000                                  
        equity securities forward contract
      		                      340,000 75,534,000                                  
        prepaid investment
      		                      42,900,000 93,956,000                                  
        senior secured notes payable - short term
      		                       113,401,000                                  
        other investments
      		                            8,195,000 8,195,000 8,195,000 8,195,000 8,195,000                         
        accounts payable and accrued expenses
      		                          8,268,000 9,461,000 11,448,000 8,347,000 9,067,000 8,855,000 9,040,000 9,239,000 11,712,000 22,688,000 11,424,000 14,580,000 17,347,000 17,477,000 11,525,000 12,705,000 14,860,000 16,564,000 16,788,000 12,295,000 11,555,000       8,407,000 6,625,000 7,201,000 9,179,000 
        other current liabilities
      		                          29,000 35,000                              
        other liabilities
      		                          2,050,000 2,131,000 916,000 1,674,000 1,874,000 2,471,000 1,805,000 577,000 380,000 362,000 354,000 345,000 311,000 291,000 271,000 250,000 228,000 310,000 319,000 319,000 319,000 1,322,000 2,323,000 494,000 415,000 659,000 654,000 642,000 632,000 608,000 649,000 
        liabilities and stockholders’ equity
      		                                                         
        stockholders’ equity:
      		                                                         
        total acacia research corporation stockholders’ equity
      		                            185,001,000 189,393,000 200,298,000 232,863,000 265,460,000 243,696,000 256,128,000 272,882,000 262,902,000 302,048,000 310,211,000 429,986,000 461,294,000 468,150,000 483,557,000 501,538,000 516,243,000 528,881,000 555,710,000 597,129,000 610,985,000 623,448,000 611,502,000 615,977,000 619,836,000     
        total stockholders’ equity
      		                            186,834,000 191,240,000 202,142,000 234,376,000 267,053,000 245,247,000 257,691,000 275,002,000 266,566,000 306,060,000 314,155,000 439,475,000 470,826,000 473,219,000 489,048,000 506,926,000 522,051,000 535,220,000 562,198,000 605,273,000 618,904,000 632,344,000 618,478,000 621,605,000 623,704,000     
        accumulated comprehensive loss
      		                              -122,000 -202,000 -125,000 -62,000 -49,000 -59,000 -171,000 -148,000 -215,000 -233,000 -413,000 -440,000 -353,000 -781,000 -784,000 -976,000 -947,000 -783,000 -658,000 -317,000 -1,166,000    -1,830,000 -1,913,000  
        noncontrolling interests in operating subsidiaries
      		                             1,847,000    1,551,000 1,563,000 2,120,000 3,664,000 4,012,000 3,944,000 9,489,000 9,532,000 5,069,000 5,491,000 5,388,000 5,808,000 6,339,000 6,488,000 8,144,000 7,919,000 8,896,000 6,976,000 5,628,000 3,868,000 3,808,000 2,163,000 1,608,000 4,182,000 
        short-term investments - debt securities
      		                              30,837,000                           
        short-term investments - equity securities
      		                              3,011,000                           
        other assets
      		                              183,000 187,000 1,193,000 407,000 336,000 365,000 365,000 1,111,000 1,110,000 353,000 355,000 355,000 355,000 351,000 350,000 309,000 318,000 1,016,000 986,000 138,000 137,000 417,000 462,000 465,000 465,000 467,000 513,000 
        short-term investments
      		                               34,694,000 29,359,000 55,052,000 90,927,000 30,326,000 32,243,000    37,090,000 53,289,000 58,558,000 72,459,000 74,798,000 95,590,000 130,017,000 166,998,000 171,216,000 134,287,000 89,475,000 146,647,000 132,496,000 134,185,000 6,597,000 6,514,000  
        investment - equity method
      		                                 2,400,000                        
        loan receivable and accrued interest
      		                                  19,749,000 8,474,000                      
        investment in warrants and shares
      		                                  2,196,000                       
        property and equipment
      		                                  94,000 155,000 189,000 231,000  319,000 374,000 421,000  634,000 701,000 782,000 766,000 778,000 607,000 536,000 339,000 317,000 342,000 212,000 220,000 232,000 172,000 
        deferred income taxes
      		                                   210,000 210,000 210,000 210,000 1,161,000 1,161,000 1,161,000 1,161,000 3,139,000 3,139,000 3,747,000 4,874,000 17,748,000 17,279,000 27,831,000 27,831,000 33,616,000 32,592,000 32,363,000    
        investment at cost
      		                                   1,720,000                      
        patents
      		                                   94,716,000 100,958,000 151,882,000                    
        deferred income tax
      		                                      210,000    1,161,000   3,139,000 3,139,000 19,974,000          
        furniture and equipment, net of accumulated depreciation and amortization
      		                                      272,000    500,000               
        accrued patent acquisition costs
      		                                              4,000,000 8,750,000 6,508,000         
        accounts payable and accrued expenses / costs
      		                                               16,310,000 15,592,000 17,127,000 9,485,000 16,388,000 18,648,000     
        investments - noncurrent
      		                                                    1,506,000 1,956,000 1,956,000 1,956,000 1,975,000 
        accumulated comprehensive income
      		                                                   382,000 797,000 600,000    
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 
                        
          cash flows from operating activities:
        		                
          net income including noncontrolling interests in subsidiaries
        		4,773,000 -2,394,000 -1,437,000 23,528,000 -14,023,000 -11,657,000 -8,829,000 -189,000 75,500,000 2,762,000 -18,779,000 9,447,000 -18,579,000 28,396,000 -47,490,000 -73,266,000 
          adjustments to reconcile net income including noncontrolling interests in subsidiaries to net cash from operating activities:
        		                
          depreciation, depletion and amortization
        		10,457,000 10,836,000 11,445,000 10,610,000 11,839,000 9,762,000 7,405,000 4,568,000         
          accretion of asset retirement obligation
        		435,000 432,000 433,000 434,000 366,000 366,000           
          loss on disposal of assets
        		                
          compensation expense for share-based awards
        		1,987,000 1,875,000 954,000 922,000 2,265,000 781,000 891,000 858,000 973,000 973,000 874,000 477,000 532,000 1,031,000 1,083,000 1,174,000 
          loss on foreign currency exchange
        		            -1,206,000 1,903,000 1,814,000 813,000 
          change in fair value of equity securities
        		-2,750,000 -900,000 -2,219,000 4,777,000 -4,107,000 4,074,000 4,744,000 26,701,000 -12,640,000 -8,823,000 -6,617,000 -3,343,000 -2,507,000 36,352,000 57,647,000 172,203,000 
          loss on sale of equity securities
        		                
          unrealized loss on derivatives
        		   4,978,000   2,772,000 629,000         
          deferred income taxes
        		1,230,000 -37,000    5,430,000 -7,287,000 -3,652,000 -2,594,000 -446,000 -377,000 -240,000 -1,839,000 -471,000 -461,000 -15,039,000 
          changes in operating assets and liabilities:
        		                
          accounts receivable
        		948,000 -3,785,000 72,315,000 -68,814,000 -485,000 7,983,000 -3,429,000 65,156,000 -73,295,000 353,000 3,080,000 -451,000 -1,244,000 6,581,000 -4,657,000 318,000 
          inventories
        		-783,000 -765,000 540,000 1,220,000 2,351,000 71,000 -2,409,000 1,041,000 1,454,000 1,631,000 719,000 -503,000 -419,000 -1,747,000 -2,041,000 -1,084,000 
          prepaid expenses and other assets
        		-2,002,000 830,000 -4,842,000 728,000 -5,956,000 576,000 6,803,000 -10,752,000 575,000 370,000 -1,374,000 -391,000 -4,908,000 2,057,000 -1,889,000 -1,246,000 
          accounts payable and accrued expenses
        		-2,312,000 2,904,000 1,328,000 1,223,000 -16,253,000 -12,400,000 13,421,000 7,108,000 972,000 5,001,000 -12,979,000 2,355,000 -5,120,000 4,261,000 -3,538,000 4,261,000 
          royalties and contingent legal fees payable
        		-217,000 1,298,000 -21,018,000 21,249,000 -745,000 1,324,000 1,894,000 -7,811,000 154,000 717,000 -480,000 360,000 -2,559,000 677,000 279,000 -161,000 
          deferred revenue
        		-90,000 24,000 157,000 7,000 202,000 454,000 -184,000 25,000 -188,000 89,000 -167,000 -71,000 -271,000 66,000 -113,000 418,000 
          net cash from operating activities
        		13,150,000 9,547,000 50,120,000 2,425,000 -20,262,000 -571,000 16,116,000 54,839,000 -4,544,000 1,160,000 -14,773,000 -4,349,000 -23,738,000 3,955,000 -14,390,000 -3,163,000 
          capital expenditures
        		-1,119,000 -461,000 0 -2,090,000 -3,290,000 -2,234,000 -142,873,000 -270,000 -37,000 -15,000 -54,000 -83,000 -180,000 -142,000 -376,000 -34,000 
          free cash flows
        		12,031,000 9,086,000 50,120,000 335,000 -23,552,000 -2,805,000 -126,757,000 54,569,000 -4,581,000 1,145,000 -14,827,000 -4,432,000 -23,918,000 3,813,000 -14,766,000 -3,197,000 
          cash flows from investing activities:
        		                
          acquisition, net of cash acquired and working capital adjustments
        		0 0 0 1,230,000             
          patent acquisition
        		    0 -5,000,000       0 0   
          proceeds from sale of floor mat assets
        		                
          purchases of equity securities
        		-7,337,000 -4,825,000 -7,716,000 -4,827,000 -4,928,000 0 0 -15,544,000 -4,394,000 -2,835,000 -677,000 -5,166,000 -4,605,000 0 -14,660,000 -92,877,000 
          sales of equity securities
        		16,192,000 0 8,439,000 6,726,000 0 0 0 57,854,000 16,908,000 0 7,166,000 8,032,000 37,770,000 44,670,000 88,652,000 102,842,000 
          purchases of loans receivable
        		-11,819,000                
          purchases of property and equipment
        		-1,119,000 -461,000       -37,000 -15,000 -54,000 -83,000 -180,000 -142,000 -376,000 -34,000 
          net additions to oil and gas properties
        		-5,213,000 -5,598,000               
          net cash from investing activities
        		-6,308,000 -14,248,000 -1,490,000 1,039,000 -95,896,000 -7,234,000 -151,873,000 42,040,000 7,561,000 -601,000 6,435,000 2,783,000 60,211,000 45,706,000 68,616,000 9,931,000 
          cash flows from financing activities:
        		                
          repurchase of common stock
        		    -12,985,000        0 -11,480,000 -28,520,000 -10,988,000 
          contributions from noncontrolling interest
        		    0 0           
          borrowings on the benchmark revolving credit facility
        		1,000,000                
          paydown of benchmark revolving credit facility
        		0 -3,500,000               
          borrowings on the deflecto facility
        		                
          paydown of deflecto facility
        		-2,988,000                
          taxes paid related to net share settlement of share-based awards
        		-5,000 0 -199,000 -471,000 -24,000 0 -394,000 -674,000 -19,000 0 -179,000 -416,000 -80,000 -1,017,000 -431,000 -72,000 
          proceeds from exercise of stock options
        		0 0   0 0   0 29,000       
          net cash from financing activities
        		-1,993,000 -10,400,000 -4,269,000 -6,071,000 30,979,000 -19,303,000 84,054,000 1,826,000 -7,719,000 -10,971,000 -673,000 77,995,000 8,470,000 -68,197,000 -79,650,000 -26,760,000 
          effect of exchange rates on cash and cash equivalents
        		90,000 160,000 396,000 691,000 -991,000 170,000 -71,000 -34,000 60,000 -43,000 -28,000 12,000 969,000    
          increase in cash and cash equivalents
        		4,939,000 -14,941,000 44,757,000 -1,916,000 -86,170,000 -26,938,000 -51,774,000 98,671,000 -4,642,000 -10,455,000 -9,039,000 76,441,000     
          cash and cash equivalents, beginning of period
        		                
          cash and cash equivalents, end of period
        		                
          supplemental schedule of cash flow information:
        		                
          interest paid
        		    2,351,000 2,258,000 130,000 319,000 133,000 580,000   1,798,000 552,000   
          income taxes paid
        		    588,000 76,000 268,000 116,000 109,000 171,000 404,000 147,000 175,000 172,000 35,000 2,000 
          noncash investing and financing activities:
        		                
          operating lease right-of-use assets obtained in exchange for lease liabilities
        		                
          derecognition of operating lease right-of-use assets upon lease termination
        		                
          derecognition of operating lease liabilities upon lease termination
        		                
          patent acquisition of prepaid option
        		0 0 0 15,000,000             
          (gain) loss on foreign currency exchange
        		 30,000 -280,000 -155,000     -28,000 70,000 -15,000 -80,000     
          gain on sale of equity securities
        		 0 -1,907,000 -1,605,000     1,570,000 0 7,999,000 1,361,000 -10,884,000 -36,060,000 -11,498,000 -66,876,000 
          unrealized gain on derivatives
        		    4,528,000            
          changes in assets and liabilities:
        		                
          cash and cash equivalents, beginning
        		 0 0 273,880,000 0 0 0 340,091,000 0 0 0 287,786,000     
          cash and cash equivalents, ending
        		 -14,941,000 44,757,000 271,964,000 -86,170,000 -26,938,000 -51,774,000 438,762,000 -4,642,000 -10,455,000 -9,039,000 364,227,000     
          amortization of debt discount and issuance costs
        		            0 34,000 5,000 51,000 
          unrealized (gain) loss on derivatives
        		                
          paydown of deflecto term loan
        		                
          accrued patent costs
        		      9,000,000 -4,000,000    6,000,000     
          deferred income taxes, net of acquired net deferred tax assets
        		   3,323,000             
          purchases of property and equipment and additions to oil and gas properties
        		   -2,090,000             
          borrowings on the revolving credit facility
        		    14,535,000 0 68,975,000 2,500,000         
          paydown of revolving credit facility
        		   -5,000,000 -18,035,000            
          paydown of term loan
        		   -600,000             
          change in fair value of series a redeemable convertible preferred stock embedded derivatives
        		        0 0 1,069,000 -5,023,000 -5,554,000 -1,210,000 9,093,000 -3,942,000 
          change in fair value of series b warrants
        		        0 0 8,866,000 -11,628,000 25,038,000 -37,039,000 23,663,000 -23,260,000 
          gain on exercise of series b warrants
        		        0        
          gain on foreign currency exchange
        		    298,000 -16,000 70,000 18,000         
          (gain) loss on sale of equity securities
        		    0 0 0 -28,861,000         
          earnings on equity investment in joint venture
        		        -792,000    404,000 -850,000   
          acquisition, net of cash acquired
        		                
          cash reinvested
        		                
          distributions received from equity investment in joint venture
        		        528,000    27,226,000    
          net purchases of property and equipment and additions to oil and gas properties
        		    -3,290,000 -2,234,000 -142,873,000 -270,000         
          paydown of senior secured notes
        		        0    0 -55,000,000 -50,000,000 -15,000,000 
          borrowings on the term loan
        		                
          dividend on series a redeemable convertible preferred stock
        		        0 0 -700,000 -700,000 -700,000 -700,000 -699,000 -700,000 
          proceeds from rights offering
        		        0 0 0 79,111,000     
          proceeds from exercise of series b warrants
        		        0        
          distribution to noncontrolling interests in subsidiaries
        		        264,000    13,540,000    
          change in fair value of series a warrants
        		            0 -3,389,000 2,390,000 -896,000 
          loss on exercise of series a warrants
        		                
          proceeds from exercise of series a warrants
        		                
          depreciation and amortization
        		         3,363,000 3,408,000 3,381,000 3,374,000 3,363,000 3,408,000 3,369,000 
          change in fair value of investment
        		                
          gain on sale of investment
        		                
          sale of investment at fair value
        		                
          cash distributed for notes receivable
        		                
          issuance of senior secured notes, net of lender fee
        		                
          increase in cash and cash equivalents and restricted cash
        		            45,912,000 -22,071,000   
          cash and cash equivalents and restricted cash, beginning
        		            0 0 0 309,361,000 
          cash and cash equivalents and restricted cash, ending
        		            45,912,000 -22,071,000 -25,424,000 289,369,000 
          patent acquisition in exchange of notes receivable
        		                
          patent acquisition accrued liabilities
        		                
          decrease in cash and cash equivalents and restricted cash
        		               -19,992,000 
          gain on sale of prepaid investment and derivative
        		                
          deferred income tax liabilities
        		                
          maturities and sales of debt securities
        		                
          acquisition of life sciences portfolio equity securities
        		                
          distributions to noncontrolling interests in operating subsidiary
        		                
          senior secured notes issuance costs paid to other parties
        		                
          issuance of series b warrants